本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Jasper Therapeutics

5.41
+0.03000.56%
盤後5.410.00000.00%17:56 EDT
成交量:12.59萬
成交額:68.10萬
市值:8,126.97萬
市盈率:-1.11
高:5.57
開:5.40
低:5.23
收:5.38
資料載入中...
2025/03/25

SEC問詢函

Form CORRESP - Correspondence
2025/03/19

重要事件披露

Form 8-K - Current report
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments